Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    November 2022
  1. KANDA Y, Mori T, Narita A, Wolter KD, et al
    Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
    Int J Hematol. 2022 Nov 28. doi: 10.1007/s12185-022-03496.
    PubMed     Abstract available


  2. NAKAMURA Y, Mori T, Kako S, Yamazaki H, et al
    Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
    Int J Hematol. 2022 Nov 15. pii: 10.1007/s12185-022-03487.
    PubMed     Abstract available


  3. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Nov 8. pii: 10.1007/s12185-022-03485.
    PubMed    


  4. MORITA Y, Nannya Y, Ichikawa M, Hanamoto H, et al
    ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial.
    Int J Hematol. 2022;116:659-668.
    PubMed     Abstract available


  5. LEE FW, Lee CY, Hung GY, Tseng MH, et al
    Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.
    Int J Hematol. 2022;116:812-818.
    PubMed     Abstract available


    September 2022
  6. CHEN CY, Chen TT, Hsieh CY, Lien MY, et al
    Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.
    Int J Hematol. 2022 Sep 4. pii: 10.1007/s12185-022-03445.
    PubMed     Abstract available


    August 2022
  7. CAMASCHELLA C, Pagani A, Silvestri L, Nai A, et al
    The mutual crosstalk between iron and erythropoiesis.
    Int J Hematol. 2022;116:182-191.
    PubMed     Abstract available


  8. MIYAZAKI Y, Kiguchi T, Sato S, Usuki K, et al
    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
    Int J Hematol. 2022;116:228-238.
    PubMed     Abstract available


    July 2022
  9. KAWABATA H, Tamura T, Tamai S, Takahashi T, et al
    Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study.
    Int J Hematol. 2022 Jul 22. pii: 10.1007/s12185-022-03420.
    PubMed     Abstract available


  10. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Jul 6. pii: 10.1007/s12185-022-03401.
    PubMed     Abstract available


  11. KAMURA Y, Sakamoto T, Yokoyama Y, Nishikii H, et al
    Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2022;116:55-59.
    PubMed     Abstract available


  12. SAKAGUCHI H, Yoshida N
    Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2022;116:16-27.
    PubMed     Abstract available


    June 2022
  13. MURAKAMI D, Matsuda K, Honda A, Masamoto Y, et al
    Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia.
    Int J Hematol. 2022 Jun 24. pii: 10.1007/s12185-022-03399.
    PubMed     Abstract available


  14. KAWAKAMI F, Kawakami T, Yamane T, Maruyama M, et al
    T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Int J Hematol. 2022;115:816-825.
    PubMed     Abstract available


    April 2022
  15. JITPIRASAKUN S, Pooliam J, Sriwichakorn C, Sanpakit K, et al
    Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/beta-thalassemia and those achieving successful hematopoietic stem-cell transplantation.
    Int J Hematol. 2022;115:575-584.
    PubMed     Abstract available


  16. IKEZOE T, Noji H, Ueda Y, Kanda Y, et al
    Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan.
    Int J Hematol. 2022;115:470-480.
    PubMed     Abstract available


  17. HAYAMA K, Abe Y, Kamata H, Okina S, et al
    Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.
    Int J Hematol. 2022;115:508-514.
    PubMed     Abstract available


    March 2022
  18. YOUSSRY I, ElGhamrawy M, Seif H, Balsamo L, et al
    Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt.
    Int J Hematol. 2022;115:399-405.
    PubMed     Abstract available


  19. HIDAKA D, Ogasawara R, Sugimura S, Fujii F, et al
    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2022;115:424-427.
    PubMed     Abstract available


    February 2022
  20. SAMPAGAR A, Gosavi M, Kedar P, Patel T, et al
    Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report.
    Int J Hematol. 2022;115:255-262.
    PubMed     Abstract available


    January 2022
  21. ELENGA N, Vantilcke V, Martin E, Cuadro E, et al
    Red blood cell exchange in children with sickle cell disease.
    Int J Hematol. 2022;115:107-113.
    PubMed     Abstract available


    September 2021
  22. WANG Z, Sun W, Chen H, Zhang Y, et al
    Prevalence and molecular spectrum of alpha- and beta-globin gene mutations in Hainan, China.
    Int J Hematol. 2021;114:307-318.
    PubMed     Abstract available


    July 2021
  23. GASIOR KABAT M, Bueno D, Sisinni L, De Paz R, et al
    Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
    Int J Hematol. 2021;114:116-123.
    PubMed     Abstract available


  24. LIU X, Cheng L, He Y, Zhang R, et al
    Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
    Int J Hematol. 2021;114:124-128.
    PubMed     Abstract available


  25. JANOWIAK-MAJERANOWSKA A, Majeranowski A
    Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;114:147-148.
    PubMed    


    June 2021
  26. YOSHINARI H, Kawahara Y, Niijima H, Oh Y, et al
    Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
    Int J Hematol. 2021 Jun 10. pii: 10.1007/s12185-021-03165.
    PubMed     Abstract available


    May 2021
  27. MAHE K, Couturaud F, Kerspern H, Chauveau A, et al
    Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
    Int J Hematol. 2021 May 22. pii: 10.1007/s12185-021-03164.
    PubMed     Abstract available


    April 2021
  28. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    PubMed     Abstract available


  29. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.
    PubMed    


  30. LERTKOVIT O, Anurathapan U, Hongeng S, Thokanit NS, et al
    Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:556-565.
    PubMed     Abstract available


    March 2021
  31. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    PubMed     Abstract available


  32. OTSUKA H, Endo Y, Ohtsu H, Inoue S, et al
    Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.
    Int J Hematol. 2021;113:348-361.
    PubMed     Abstract available


    February 2021
  33. VIVES-CORRONS JL, Krishnevskaya E, Rodriguez IH, Ancochea A, et al
    Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
    Int J Hematol. 2021;113:163-174.
    PubMed     Abstract available


  34. PINCZES LI, Szabo R, Miltenyi Z, Illes A, et al
    The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int J Hematol. 2021;113:175-182.
    PubMed     Abstract available


    January 2021
  35. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    PubMed     Abstract available


  36. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    PubMed     Abstract available


    December 2020
  37. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    PubMed     Abstract available


    October 2020
  38. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    PubMed     Abstract available


  39. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    PubMed     Abstract available


    September 2020
  40. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    PubMed     Abstract available


    June 2020
  41. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    PubMed     Abstract available


    May 2020
  42. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: